AstraZeneca AB v. Sun Pharma Global FZE et al
| Delaware District Court | |
| Judge: | Gregory M Sleet |
| Case #: | 1:14-cv-00694 |
| Nature of Suit | 830 Property Rights - Patent |
| Cause | 35:271 Patent Infringement |
| Case Filed: | Jun 02, 2014 |
| Terminated: | Feb 02, 2017 |
| Last checked: Tuesday Jan 20, 2015 1:11 AM EST |
|
Counter Claimant
Sun Pharma Global FZE
|
Represented By
|
|
Counter Claimant
Sun Pharmaceutical Industries Ltd.
|
Represented By
|
|
Counter Defendant
AstraZeneca AB
|
Represented By
|
|
Defendant
Sun Pharma Global FZE
|
Represented By
|
|
Defendant
Sun Pharmaceutical Industries Ltd.
|
Represented By
|
|
Plaintiff
AstraZeneca AB
|
Represented By
|
| TERMINATED PARTIES | |
|
Defendant
Caraco Pharmaceutical Laboratories Ltd.
Terminated: 06/25/2014
|
|
| Docket last updated: 07/13/2023 11:59 PM EDT |
| Thursday, February 02, 2017 | ||
| 25 | 25
misc
Patent/Trademark Report to Commissioner of Patents
Thu 02/02 4:32 PM
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (mdb) |
|
| 24 | 24
order
Judgment
Thu 02/02 4:21 PM
JUDGMENT entered in favor of the plaintiff and against defendant. CASE CLOSED. Signed by Judge Gregory M. Sleet on 2/2/2017. Associated Cases: 1:14-cv-00664-GMS et al.(mdb) |
|
| Tuesday, October 21, 2014 | ||
| 23 | 23
ORDER: On or before Monday, November 10, 2014, each party or each party group shall email to Chief Magistrate Judge Thynge, with a copy to her Judicial Administrator, Cathleen Kennedy, the information requested in the Order. Signed by Judge Mary Pat Thynge on 10/21/14. (cak) (cak).
|
|
| CORRECTING ENTRY: Added Order to DI 27 in 14-664; DI 27 in 14-665; DI 21 in 14-666; DI 22 in 667; DI 23 in 15-694; DI 19 in 14-695; DI 19 in 14-697; DI 23 in 14-698; DI 17 in 14-845; and DI 17 in 14-1051 Associated Cases: 1:14-cv-00664-GMS et al.(cak) | ||
| Wednesday, October 15, 2014 | ||
| 22 | 22
Official Transcript of Conference held on 10 08 14 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 11/5/2014. Redacted Transcript Deadline set for 11/17/2014. Release of Transcript Restriction set for 1/13/2015. (kjm)
|
|
| Wednesday, October 08, 2014 | ||
| Minute Entry for proceedings held before Judge Gregory M. Sleet - Scheduling Conference held on 10/8/2014. Joinder of Parties due 3/6/2015; Amendment of Pleadings due 9/15/2015; Claim Construction Briefing: Opening due 6/26/2015, Answering due 7/24/2015; A Markman Hearing (4 hrs.) is set for 9/25/2015 at 9:30 AM in Courtroom 4A; Fact Discovery to be completed by 10/16/2015; Expert Discovery: Opening Reports due 11/6/2015, Rebuttal Reports due 12/18/2015, Completed by 3/18/2016; Pretrial Order due by 6:00 PM on 8/1/2016; A Pretrial Conference (by telephone, tentatively) is set for 9/7/2016 at 10:00 AM in Chambers; A 10-day Bench Trial is set for 9/19/2016 at 9:00 AM in Courtroom 4A. THESE CASES ARE CONSOLIDATED FOR ALL PURPOSES. Plaintiff's counsel shall file the proposed case management order by 10/17/2014. (Court Reporter Kevin Maurer.) Associated Cases: 1:14-cv-00664-GMS et al.(mdb) | ||
| Remark: Cases are CONSOLIDATED FOR ALL PURPOSES. All future filings, except those involving the pending motions in 14-cv-696 and 14-cv-665, shall be filed in 14-cv-664 ONLY. Case associated with lead case: Create association to 1:14-cv-00664-GMS. Associated Cases: 1:14-cv-00665-GMS et al.(mdb) | ||
| Wednesday, October 01, 2014 | ||
| 21 | 21
PROPOSED ORDER Scheduling by AstraZeneca AB. (Silver, Daniel)
|
|
| 20 | 20
Joint STATUS REPORT by AstraZeneca AB.(Silver, Daniel)
|
|
|
Att: 1
Exhibit A,
|
||
|
Att: 2
Exhibit B
|
||
| Tuesday, September 30, 2014 | ||
| 19 | 19
NOTICE OF SERVICE of (1) Plaintiff's First Set of Requests to Sun for the Production of Documents and Things (Nos. 1-15) and (2) Plaintiff's First Set of Interrogatories to Sun (Nos. 1-7) filed by AstraZeneca AB.(Silver, Daniel)
|
|
| Tuesday, September 23, 2014 | ||
| 18 | 18
Amended Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than April 25, 2014. Date of Expiration of Patent: 7,951,400 (November 30, 2028); RE44,186 (July 31, 2023); 8,628,799 (July 13, 2025).Thirty Month Stay Deadline: 1/31/2017. (Silver, Daniel)
|
|
| ORAL ORDER SCHEDULING A RULE 16.2b CONFERENCE IN COURTROOM 4A: A Rule 16.2b Scheduling Conference has been set in these related matters for Wednesday, October 8, 2014, at 10:00 AM with the Honorable Gregory M. Sleet in Courtroom 4A. The parties shall file a Joint Status Report (see court's website for sample) no later than NOON on Wednesday, October 1, 2014. Ordered by Judge Gregory M. Sleet on 9/23/2014. (ctd) | ||
| Tuesday, August 26, 2014 | ||
| 17 | 17
NOTICE of Appearance by David A. Bilson on behalf of Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd. (Bilson, David)
|
|
| Monday, July 28, 2014 | ||
| Pro Hac Vice Attorney John K. Hsu for Sun Pharma Global FZE added for electronic noticing. (dmp, ) | ||
| Tuesday, July 22, 2014 | ||
| Pro Hac Vice Attorney James F. Hurst for Amneal Pharmaceuticals LLC,James F. Hurst for Sun Pharma Global FZE added for electronic noticing. Associated Cases: 1:14-cv-00697-GMS, 1:14-cv-00694-GMS(els) | ||
| Pro Hac Vice Attorney Maureen L. Rurka for Amneal Pharmaceuticals LLC,Maureen L. Rurka for Sun Pharma Global FZE added for electronic noticing. Associated Cases: 1:14-cv-00697-GMS, 1:14-cv-00694-GMS(els) | ||
| Pro Hac Vice Attorney Charles B. Klein for Amneal Pharmaceuticals LLC,Charles B. Klein for Sun Pharma Global FZE added for electronic noticing. Associated Cases: 1:14-cv-00697-GMS, 1:14-cv-00694-GMS(els) | ||
| Pro Hac Vice Attorney Charles P. Wilson for Amneal Pharmaceuticals LLC,Charles P. Wilson for Sun Pharma Global FZE added for electronic noticing. Associated Cases: 1:14-cv-00697-GMS, 1:14-cv-00694-GMS(els) | ||
| Pro Hac Vice Attorney Samuel S. Park for Amneal Pharmaceuticals LLC,Samuel S. Park for Sun Pharma Global FZE added for electronic noticing. Associated Cases: 1:14-cv-00697-GMS, 1:14-cv-00694-GMS(els) | ||
| Friday, July 18, 2014 | ||
| Pro Hac Vice Attorney Charles E. Lipsey for AstraZeneca AB added for electronic noticing. Associated Cases: 1:14-cv-00664-GMS et al.(dmp, ) | ||
| Thursday, July 17, 2014 | ||
| 16 | 16
ANSWER to12 Answer to Complaint, Counterclaim AstraZeneca AB's Reply to Sun's Counterclaims by AstraZeneca AB.(Silver, Daniel)
|
|
| SO ORDERED - re (15 in 1:14-cv-00666-GMS, 13 in 1:14-cv-00667-GMS, 11 in 1:14-cv-00698-GMS, 10 in 1:14-cv-00697-GMS, 11 in 1:14-cv-00664-GMS, 7 in 1:14-cv-00845-GMS, 12 in 1:14-cv-00665-GMS, 10 in 1:14-cv-00695-GMS, 14 in 1:14-cv-00694-GMS) MOTION for Pro Hac Vice Appearance of Attorney Charles E. Lipsey, James B. Monroe, Robert F. Shaffer and Maximilienne Bishop filed by AstraZeneca AB, AstraZeneca AB. Ordered by Judge Gregory M. Sleet on 7/17/2014. Associated Cases: 1:14-cv-00664-GMS et al.(mdb) Modified on 7/17/2014 (mdb). | ||
| SO ORDERED - re (15 in 1:14-cv-00694-GMS) MOTION for Pro Hac Vice Appearance of Attorney James F. Hurst, Samuel Park, Maureen L. Rurka, Charles B. Klein, John K. Hsu and Christopher P. Wilson filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., (11 in 1:14-cv-00697-GMS) MOTION for Pro Hac Vice Appearance of Attorney James F. Hurst, Samuel Park, Maureen L. Rurka, Charles B. Klein, John K. Hsu and Christopher P. Wilson filed by Amneal Pharmaceuticals LLC. Ordered by Judge Gregory M. Sleet on 7/17/2014. (mdb) | ||
| Pro Hac Vice Attorney Maximilienne Bishop for AstraZeneca AB added for electronic noticing. Associated Cases: 1:14-cv-00664-GMS et al.(dmp, ) | ||
| Tuesday, July 15, 2014 | ||
| 15 | 15
MOTION for Pro Hac Vice Appearance of Attorney James F. Hurst, Samuel Park, Maureen L. Rurka, Charles B. Klein, John K. Hsu and Christopher P. Wilson - filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd..(Haney, Megan)
|
|
|
Att: 1
Hurst Pro Hac Certification,
|
||
|
Att: 2
Park Pro Hac Certification,
|
||
|
Att: 3
Rurka Pro Hac Certification,
|
||
|
Att: 4
Klein Pro Hac Certification,
|
||
|
Att: 5
Hsu Pro Hac Certification,
|
||
|
Att: 6
Wilson Pro Hac Certification
|
||
| Monday, July 14, 2014 | ||
| 14 | 14
MOTION for Pro Hac Vice Appearance of Attorney Charles E. Lipsey, James B. Monroe, Robert F. Shaffer and Maximilienne Bishop - filed by AstraZeneca AB, AstraZeneca AB.(Silver, Daniel)
|
|
|
Att: 1
Certification of Charles E. Lipsey,
|
||
|
Att: 2
Certification of James B. Monroe,
|
||
|
Att: 3
Certification of Robert F. Shaffer,
|
||
|
Att: 4
Certification of Maximilienne Bishop
|
||
| Thursday, June 26, 2014 | ||
| 13 | 13
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sun Pharmaceutical Industries, Ltd. for Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd. filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd.. (Phillips, John)
|
|
| 12 | 12
ANSWER to1 Complaint, Affirmative Defenses , COUNTERCLAIM against AstraZeneca AB by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd..(Phillips, John)
|
|
| Wednesday, June 25, 2014 | ||
| 11 | 11
SO ORDERED - re10 Stipulation filed by AstraZeneca AB; Party Caraco Pharmaceutical Laboratories Ltd. terminated. Signed by Chief Judge Gregory M. Sleet on 6/25/2014. (mdb)
|
|
| Tuesday, June 24, 2014 | ||
| 10 | 10
STIPULATION and Order Dismissing Defendant Caraco Pharmaceutical Laboratories LTD. by AstraZeneca AB. (Silver, Daniel)
|
|
| Monday, June 16, 2014 | ||
| 9 | 9
ACKNOWLEDGEMENT OF SERVICE Executed on behalf of Defendant Sun Pharmaceutical Industries Ltd. Acknowledgement filed by AstraZeneca AB. (Silver, Daniel)
|
|
| Tuesday, June 10, 2014 | ||
| 8 | 8
DECLARATION of Mailing Regarding Service on Sun Pharma Global FZE made on June 5, 2014 by AstraZeneca AB.(Silver, Daniel)
|
|
|
Att: 1
Exhibit A & B
|
||
| 7 | 7
DECLARATION of Mailing Regarding Service on Caraco Pharmaceutical Laboratories Ltd. made on June 5, 2014 by AstraZeneca AB.(Silver, Daniel)
|
|
|
Att: 1
Exhibit A & B
|
||
| 6 | 6
Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca AB filed by AstraZeneca AB. (Kelly, Michael)
|
|
| Wednesday, June 04, 2014 | ||
| Summons Reissued with Magistrate Consent Notice attached as to Sun Pharma Global FZE. (rbe) | ||
| Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. Associated Cases: 1:14-cv-00694-GMS, 1:14-cv-00695-GMS, 1:14-cv-00696-GMS, 1:14-cv-00697-GMS, 1:14-cv-00698-GMS (rjb) | ||
| Tuesday, June 03, 2014 | ||
| Summons Issued with Magistrate Consent Notice attached as to Caraco Pharmaceutical Laboratories Ltd. on 6/3/2014; Sun Pharma Global FZE on 6/3/2014. (rwc) | ||
| Monday, June 02, 2014 | ||
| 5 | 5
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC, Corporate Parent Zeneca Wilmington Inc. for AstraZeneca AB filed by AstraZeneca AB. (dmp, )
|
|
| 4 | 4
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE44,186; 7,951,400; 8,628,799;. (dmp, )
|
|
| 3 | 3
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than 4/25/14. Date of Expiration of Patent: See attached.Thirty Month Stay Deadline: 10/26/2016. (dmp, )
|
|
| 2 | 2
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (dmp, )
|
|
| 1 | 1
COMPLAINT filed against Caraco Pharmaceutical Laboratories Ltd., Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1525830.) - filed by AstraZeneca AB.(dmp, )
|
|
|
Att: 1
Exhibit A,
|
||
|
Att: 2
Exhibit B,
|
||
|
Att: 3
Exhibit C,
|
||
|
Att: 4
Civil Cover Sheet
|
||
| No Summons Issued. (dmp, ) | ||